Alexandra Roger
Sanofi
Assets Managed
$335.959M
Holdings
9
Last Quarter
2026 - Q1
Filed Date
23d ago
Growth Rate
8.23%(2Q avg: 13.73%)
Sustained Growth
4 quarters
Portfolio positions
This chart displays the top 10 holdings in Sanofi's 2026 - Q1 portfolio, based on their 13F SEC filing, out of a total of 9 positions.
Assets under management
The assets under management (AUM) of Sanofi over the past 10 years (40 quarters) show continuous growth in total asset value over the last 4 quarters. As of the latest 13F SEC filing for 2026 - Q1, they manage 335.959M in assets, with a quarterly growth rate of 8.23% and a 2-quarter average growth rate of 13.73%. The portfolio is managed by Alexandra Roger, and others.
Portfolio holdings
| Investment | Portfolio % | Reported Value | Recent Activity |
|---|---|---|---|
MGTX Meiragtx Holdings Plc
| 31.45% | $105.632M 12.198M shares@ $8.66 avg price | |
INBX Inhibrx Biosciences Inc
| 23.18% | $77.847M 1.158M shares@ $67.24 avg price | |
NVAX Novavax Inc
| 16.68% | $56.007M 6.88M shares@ $8.14 avg price | |
ANAB Anaptysbio Inc
| 9.05% | $30.385M 821,917 shares@ $36.97 avg price | |
AGMB Agomab Therapeutics Nv
| 8.69% | $29.195M 2.783M shares@ $10.49 avg price | New Position |
MPLT Maplight Therapeutics Inc
| 5.52% | $18.542M 912,041 shares@ $20.34 avg price | |
IMRX Immuneering Corp - Class A
| 4.25% | $14.274M 2.709M shares@ $5.28 avg price | |
ELDN Eledon Pharmaceuticals Inc
| 0.75% | $2.51M 814,980 shares@ $3.08 avg price | |
QTTB Q32 Bio Inc
| 0.47% | $1.567M 244,083 shares@ $6.43 avg price |
1-9 of 9